Status:
COMPLETED
A Single Group Study to Evaluate the Efficacy of a Cosmetic Product Line on Acne Symptoms
Lead Sponsor:
Menning Labs
Collaborating Sponsors:
Citruslabs
Conditions:
Acne
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This twelve-week trial will examine the effectiveness of a Menning Labs EQ Product Line acne product. Participants will use the exfoliating cleanser, cream, and gel daily for 8 weeks. Participants wil...
Eligibility Criteria
Inclusion
- Be aged between 18-45.
- Anyone who has acne prone skin and a history of recurring acne.
- Has visible acne at enrollment.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- Have a digital camera or smartphone to take photos of the face.
Exclusion
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Anyone currently using a prescription skin product.
- Anyone who is unwilling to stop using the current acne supplements they are taking.
- Anyone with known severe allergic reactions.
- Any women who are pregnant, breastfeeding or attempting to become pregnant.
- Anyone unwilling to follow the study protocol.
- Anyone who identifies as having sensitive skin.
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06122467
Start Date
October 2 2023
End Date
December 31 2023
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404